Nicholas Lydon, Director at Blueprint Medicines Corp (BPMC), sold 8,250 shares at $80.13 ($661K) on 2020-07-02, disclosed to the SEC on 2020-07-06.
Open-market sale of $661k BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.21 | 1,300 | $104K | 15.8% |
| 2 | $80.21 | 1,300 | $104K | 15.8% |
| 3 | $80.13 | 2,825 | $226K | 34.2% |
| 4 | $80.13 | 2,825 | $226K | 34.2% |
| Total | $80.16 avg | 8,250 | $661K | 100% |
| Filing → |
| BPMC | SELL | 2020-07-08 | $4.1M | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $2.1M | — | Filing → |